Suchergebnisse - "Kääriäinen, Susanna"

PubPharm (6)

1

Safety, tolerability and immunogenicity of PRV-101, a multivalent vaccine targeting coxsackie B viruses (CVBs) associated with type 1 diabetes : a double-blind randomised placebo-controlled Phase I trial

enthalten in: Diabetologia | 2024

von Hyöty, H. | Kääriäinen, S. | Laiho, J. | +11

2

Safety, tolerability and immunogenicity of PRV-101, a multivalent vaccine targeting coxsackie B viruses (CVBs) associated with type 1 diabetes: a double-blind randomised placebo-controlled Phase I trial

enthalten in: Diabetologia | 2024

von Hyöty, H. | Kääriäinen, S. | Laiho, J. | +11

3

Hydroxychloroquine in the treatment of adult patients with Covid-19 infection in a primary care setting (LIBERTY) : A structured summary of a study protocol for a randomised controlled trial

enthalten in: Trials | 2021

von Vainio, P. | Hietasalo, P. | Koivisto, A. | +5

4

Hydroxychloroquine in the treatment of adult patients with Covid-19 infection in a primary care setting (LIBERTY): A structured summary of a study protocol for a randomised controlled trial

enthalten in: Trials | 2021

von Vainio, P. | Hietasalo, P. | Koivisto, A. | +5

5

Orally administered recombinant metallo-beta-lactamase preserves colonization resistance of piperacillin-tazobactam-treated mice

enthalten in: Antimicrobial agents and chemotherapy | 2005

von Stiefel, U. | Harmoinen, J. | Koski, P. | +7

6

Orally Administered Recombinant Metallo-{szligbeta}-Lactamase Preserves Colonization Resistance of Piperacillin-Tazobactam-Treated Mice

enthalten in: Antimicrobial agents and chemotherapy | 2005

von Stiefel, U. | Harmoinen, J. | Koski, P. | +6

1
[1]